Borrowings (Tables)

6 Months Ended

Jun. 30, 2023

Borrowings [Abstract]

Summary Of Borrowings

	As of June 30, 2023
(Dollars in thousands)	Maturity Date	Contractual ‎Facility		Balance, ‎Gross		Balance, ‎Net(1)		Stated ‎Interest Rate	Effective ‎Interest ‎Rate
Denominated in USD
Trust Preferred Securities (US)	April 30, 2027	$	27,913	$	27,913	$	27,061	9.30%	9.30%
Bank of America Credit Facility (US)	September 4, 2024		24,550		24,550		24,404	10.75%	10.75%
Cinemas 1, 2, 3 Term Loan (US)	October 3, 2023		22,232		22,232		22,177	6.63%	6.63%
Minetta & Orpheum Theatres Loan (US)(2)	November 1, 2023		8,000		8,000		7,990	6.00%	5.15%
U.S. Corporate Office Term Loan (US)	January 1, 2027		8,539		8,539		8,486	4.64% / 4.44%	4.61%
Union Square Financing (US)	May 6, 2024		55,000		46,155		45,593	12.06%	12.06%
Purchase Money Promissory Note (US)	September 18, 2024		964		964		964	5.00%	5.00%
Denominated in foreign currency ("FC") (3)
NAB Corporate Term Loan (AU) (4)	June 30, 2024		66,963		66,963		66,916	5.64%	5.64%
Westpac Bank Corporate (NZ)	January 1, 2024		8,488		8,488		8,488	8.20%	8.20%
		$	222,649	$	213,804	$	212,079

(1)Net of deferred financing costs amounting to $1.7 million.

(2)The interest rate derivative associated with the Minetta & Orpheum loan provides for an effective fixed rate of 5.15%.

(3)The contractual facilities and outstanding balances of the foreign currency denominated borrowings were translated into U.S. dollars based on the applicable exchange rates as of June 30, 2023.

(4)This financing arrangement was extended after June 30, 2023.

	As of December 31, 2022
(Dollars in thousands)	Maturity Date	Contractual ‎Facility		Balance, ‎Gross		Balance, ‎Net(1)		Stated ‎Interest ‎Rate	Effective ‎Interest ‎Rate
Denominated in USD
Trust Preferred Securities (US)	April 30, 2027	$	27,913	$	27,913	$	26,950	8.41%	8.41%
Bank of America Credit Facility (US)(5)	March 1, 2024		26,750		26,750		26,663	10.00%	10.00%
Cinemas 1, 2, 3 Term Loan (US)(5)	April 1, 2023		22,455		22,455		22,208	6.63%	6.63%
Minetta & Orpheum Theatres Loan (US)(2)	November 1, 2023		8,000		8,000		7,974	7.12%	6.00%
U.S. Corporate Office Term Loan (US)	January 1, 2027		8,674		8,674		8,613	4.64% / 4.44%	4.64%
Union Square Financing (US)(3)	May 6, 2024		55,000		43,000		42,484	11.25%	7.40%
Purchase Money Promissory Note (US)	September 18, 2024		1,333		1,333		1,333	5.00%	5.00%
Denominated in foreign currency ("FC")(4)
NAB Corporate Term Loan (AU)	June 30, 2024		68,731		68,731		68,662	4.82%	4.82%
Westpac Bank Corporate (NZ)	January 1, 2024		8,777		8,777		8,777	6.95%	6.95%
Total		$	227,633	$	215,633	$	213,664

(1)Net of deferred financing costs amounting to $2.0 million.

(2)The interest rate derivative associated with the Minetta & Orpheum loan provides for an effective fixed rate of 5.15%.

(3)The interest rate derivative associated with the Union Square loan provides for an effective fixed rate of 7.40%.

(4)The contractual facilities and outstanding balances of the foreign currency denominated borrowings were translated into U.S. dollars based on the applicable exchange rates as of December 31, 2022.

(5)This financing facility was extended after December 31, 2022.

Schedule Of Long-term Debt Instruments, Net Of The Deferred Financing Costs

	June 30,		December 31,
Balance Sheet Caption (Dollars in thousands)	2023		2022
Debt - current portion	$	47,259	$	37,279
Debt - long-term portion		136,993		148,688
Subordinated debt - current portion		766		747
Subordinated debt - long-term portion		27,061		26,950
Total borrowings	$	212,079	$	213,664